Trials / Completed
CompletedNCT03868904
INSPIRE Continuation Post-Approval Study
OCS Lung INSPIRE Long-Term Continuation Post-Approval Study - INSPIRE Continuation PAS
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 220 (actual)
- Sponsor
- TransMedics · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To evaluate long-term BOS-free survival outcomes of the OCS™ Lung INSPIRE Trial patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | OCS Lung System | No active interventions are part of this study. This study will collect long-term survival and BOS data in subjects who were part of the INSPIRE trial. |
Timeline
- Start date
- 2019-06-30
- Primary completion
- 2021-10-12
- Completion
- 2021-10-12
- First posted
- 2019-03-11
- Last updated
- 2022-04-07
Locations
17 sites across 9 countries: United States, Australia, Belgium, Canada, France, Germany, Italy, Spain, United Kingdom
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03868904. Inclusion in this directory is not an endorsement.